Y 7 (Sirolimus 0.5 mg)
Pill with imprint Y 7 is Gray, Round and has been identified as Sirolimus 0.5 mg. It is supplied by Glenmark Pharmaceuticals Inc..
Sirolimus is used in the treatment of lymphangioleiomyomatosis; organ transplant, rejection prophylaxis and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Sirolimus 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Y 7
Sirolimus
- Imprint
- Y 7
- Strength
- 0.5 mg
- Color
- Gray
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- MTOR inhibitors, Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Pharmaceuticals Inc.
- National Drug Code (NDC)
- 68462-0682
Related Images for "Y 7"
More about sirolimus
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- Drug class: mTOR inhibitors
- FDA Alerts (2)
Consumer resources
Other brands: Rapamune
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
